Form 4: ANI Pharmaceuticals Director Antonio R. Pera Sells 7,000 Shares
SEC Form 4 Filing
Director Antonio R. Pera of ANI Pharmaceuticals sold 7,000 shares of common stock on March 4, 2024.
Summary
- On March 4, 2024, Antonio R. Pera, a director of ANI Pharmaceuticals, sold 7,000 shares of the company's common stock.
- The sale was executed at a price of $65.2 per share.
- Following the transaction, Pera directly owns 26,627 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a transaction by a company insider. It doesn't inherently convey positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock. The sale itself may not be indicative of the company's performance or future prospects.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although it is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 03/04/2024 | Date of transaction: Antonio R. Pera sold 7,000 shares of ANI Pharmaceuticals common stock. |
| 03/06/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.